Asian Journal of Advances in Medical Science

The physiotherapy landscape in India has undergone a paradigmatic transformation, transitioning from an ancillary clinical adjunct to a cornerstone of rehabilitative and preventive medicine. Central to this evolution is the institutionalization of evidence-based practice (EBP), underpinned by the proliferation of scientifically rigorous clinical trials. Nevertheless, the expansion and efficacy of clinical trials in physiotherapy (CTPs) are persistently encumbered by a constellation of systemic impediments. These include deficient research literacy among practitioners, erratic and insufficient financial support, convoluted pharmacokinetic regulatory architectures, inadequate collaborative infrastructure, and sociocultural obstacles to participant recruitment and retention. Further exacerbating these issues are the continued reliance on antiquated therapeutic paradigms and the paucity of longitudinal efficacy assessments, which collectively hinder the extrapolation of findings to real-world clinical scenarios. This discourse critically interrogates the extant challenges confronting physiotherapy research in the Indian context and delineates a strategic schema to surmount these barriers. Proposed interventions include integrating comprehensive research education within academic curricula, the recalibration of regulatory protocols to accommodate non-pharmacological interventions, the augmentation of funding avenues, the cultivation of interdisciplinary and international consortia, and the institutionalization of culturally congruent recruitment methodologies. These measures are imperative for the maturation of a resilient and contextually adaptive research ecosystem, enabling India to emerge as a formidable contributor to the global corpus of physiotherapeutic knowledge and evidence-based clinical praxis.